A Critical Review of Quality-of-Life Scales for Psoriasis
Section snippets
Short Form 36
The Short Form 36 (SF-36) consists of 36 items that measure 8 broad topics as listed in Box 1 [2], [3]. There is an additional question on change in respondents' health in the past year. For each variable, the items are converted into a scale from 0 (worst health state) to 100 (best health state).
Sickness Impact Profile assessment
The Sickness Impact Profile (SIP) is a broadly based assessment of performance of daily activities [4]. One hundred thirty-six individual statements relating to daily activities can be agreed or
A critical review of quality-of-life measures
Articles and abstracts in which all the quality-of-life measures are used are identified by searching MEDLINE and PubMed up to December 2004. All measures are summarized in Table 1.
Which measure to use?
In choosing which quality-of-life measure to use in psoriasis, first consider the reason for its use. This could be for clinical, research, audit, or financial purposes. If psoriasis is to be compared with other nondermatologic disease, a general health-related quality-of-life questionnaire is appropriate. If it is to be compared with other skin conditions, a dermatology-specific quality-of-life measure is likely to produce a more sensitive and meaningful comparison.
When deciding on a
References (45)
- et al.
Ten years experience of the Dermatology Life Quality Index
J Invest Dermatol Symp Proc
(2004) - et al.
Skindex, a quality of life measure for patients with skin disease: reliability, validity and responsiveness
J Invest Dermatol
(1996) - et al.
Development and validation of a quality of life instrument for cutaneous diseases
J Am Acad Dermatol
(1997) Utility approach to measuring health-related quality of life
J Chronic Dis
(1987)Measures of the effect of adult severe atopic eczema on quality of life
J Eur Acad Dermatol Venereol
(1996)- et al.
The burden of psoriasis is not determined by disease severity only
J Invest Dermatol Symp Proc
(2004) - et al.
Health-related quality of life and hand eczema- a comparison of two instruments, including factor analysis
J Invest Dermatol
(2004) - et al.
Quality of life in patients with psoriasis: a systematic literature review
J Invest Dermatol Symp Proc
(2004) - et al.
A catalog of dermatology utilities: a measure of the burden of skin diseases
J Invest Dermatol Symp Proc
(2004) - et al.
The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey
Arch Dermatol
(2001)
Short form 36 (SF-36) health survey questionnaire: normative data for adults of working age
BMJ
The SF36 health survey questionnaire: an outcome measure suitable for routine clinical use within the NHS?
BMJ
The Sickness Impact Profile: development and final revision of a health status measure
Med Care
A scale version of the General Health Questionnaire
Psychol Med
The Nottingham Health Profile User's Manual
Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use
Clin Exp Dermatol
The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use
Br J Dermatol
The Children's Dermatology Life Quality Index: validation of the cartoon version
Br J Dermatol
Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin disease
Arch Dermatol
Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases
J Cutan Med Surg
Dermatology quality of life scales – a measure of the impact of skin disease
Br J Dermatol
Development of the German scale for assessing quality of life in skin diseases
Hautarzt
Cited by (23)
Characterization of health-related quality of life studies in people with psoriasis: Systematic review 2003-2013
2014, Revista Colombiana de ReumatologiaQuality-of-Life Instruments: Evaluation of the Impact of Psoriasis on Patients
2012, Dermatologic ClinicsCitation Excerpt :To be a useful QoL instrument, it should demonstrate the following criteria: (1) validity (ie, the instrument evaluates well what it intends to measure); (2) reliability (ie, the instrument is reproducible over time); (3) capable of measuring health-related QoL regardless of the disease severity (ie, the instrument can be used for patients with either mild-to-moderate or moderate-to-severe psoriasis); (4) applicable to a wide variety of patients in different clinical settings; and (5) quick and easy for patients to fill out. Several useful generic, dermatology-specific, and disease-specific QoL instruments exist to evaluate the impact of psoriasis on patient’s QoL.9–12 Specifically, generic QoL instruments given to patients with psoriasis include the Short Form 36 (SF-36),13,14 the Sickness Impact Profile (SIP),15 the General Health Questionnaire (GHQ),16 and the Psychological General Well-Being Index (PGWB).17
Impact of psoriasis in health-related quality of life
2007, Medicina ClinicaMeasuring patient quality of life following treatment for alopecia
2021, Patient Preference and Adherence
Prof. Finley is joint copyright owner of PDI, DLQI, and CDLQI. His department gains income from their use.